drugset / Trial / NCT00035113
EPO906 Therapy in Patients With Prostate Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study will examine whether the new investigational drug EPO906, given by intravenous infusion (IV directly into the vein), is effective in shrinking tumors and preventing the growth of cells that cause prostate cancer.
Timeline
- Start
- 2002-01
- Primary completion
- 2004-01
- Completion
- 2004-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Patupilone | Small molecule | — | Intravenous |